social science of hiv and hepatitis c in russia and southeastern europe

30
Social science of HIV and hepatitis C in Russia and southeastern Europe Sergii Dvoriak M.D., Ph.D Ukrainian Institute on Public Health Policy, Kyiv, Ukraine Symposium “Social and Structural Determinants of the HIV Epidemic in Eastern Europe and Central Asia” IAS 2013 7 th IAS Conference on HIV Pathogenesis, treatment and Prevention 30 June – 03 July 2013 – Kuala Lumpur, Malaysia 1

Upload: ganesa

Post on 24-Feb-2016

45 views

Category:

Documents


0 download

DESCRIPTION

Social science of HIV and hepatitis C in Russia and southeastern Europe. Sergii Dvoriak M.D., Ph.D Ukrainian Institute on Public Health Policy, Kyiv, Ukraine. Symposium “Social and Structural Determinants of the HIV Epidemic in Eastern Europe and Central Asia” - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Social science of HIV and hepatitis C in Russia and southeastern Europe

1

Social science of HIV and hepatitis C in Russia and

southeastern Europe

Sergii Dvoriak M.D., Ph.D

Ukrainian Institute on Public Health Policy,

Kyiv, Ukraine

Symposium “Social and Structural Determinants of the HIV Epidemic in Eastern Europe and Central Asia”IAS 2013 7th IAS Conference on HIV Pathogenesis, treatment and Prevention

30 June – 03 July 2013 – Kuala Lumpur, Malaysia

Page 2: Social science of HIV and hepatitis C in Russia and southeastern Europe

2

Page 3: Social science of HIV and hepatitis C in Russia and southeastern Europe

3

Page 4: Social science of HIV and hepatitis C in Russia and southeastern Europe

4

Page 5: Social science of HIV and hepatitis C in Russia and southeastern Europe

5

UNAIDS, Global Report, 2011

FACT SHEET Eastern Europe and Central Asia

A steep regional increase in new HIV infections and AIDS-related deaths

In EE&CA, the number of people living with HIV almost tripled between 2000 and 2009. An estimated 1.4 million [1.3 million–1.6 million] people were living with HIV in 2009 compared to 530 000 [470 000–620 000] in 2000.

AIDS-related deaths continue to rise in the region: an estimated 76 000 [60 000–95 000] people died from AIDS-related causes in 2009 compared to 18 000 [14 000–23 000] in 2001, a four-fold increase.

The Russian Federation and Ukraine together account for nearly 90% of newly reported HIV infections.

Ukraine has the highest adult HIV prevalence in all of Europe and Central Asia, at 1.1% [1.0%–1.3%]. Annual HIV diagnoses in Ukraine have more than doubled since 2001.

Between 2000 and 2009, the HIV incidence rate increased by more than 25% in five countries in the region: Armenia, Georgia, Kazakhstan, Kyrgyzstan and Tajikistan.

Page 6: Social science of HIV and hepatitis C in Russia and southeastern Europe

6

Social Determinants of

HealthComplex and overlapping community, social, economic, and environmental factors that influence an individual’s and a collective community’s risk for health inequities.

Page 7: Social science of HIV and hepatitis C in Russia and southeastern Europe

7

Structural factors on HIV-Epidemic

Health care andSocial welfare systemsDisease-specific public health responseTreating of vulnerable groups (PWID, Sex

workers, prison populations etc.)Evidence-based drug policy

Page 8: Social science of HIV and hepatitis C in Russia and southeastern Europe

8

BarriersUnequal distribution of wealth and power;ClassismRacismSexismHomophobiaTransphobiaNarcophobia

Page 9: Social science of HIV and hepatitis C in Russia and southeastern Europe

9

Poverty

Predisposition to DA Addiction

+ Risky Bhv

Incarceration

HIV, HCV, Mental Health

problems

Unemploymen

t

Page 10: Social science of HIV and hepatitis C in Russia and southeastern Europe

10

The HIV Epidemic in Ukraine In 1995, the WHO characterized Ukraine as a low

prevalence country. By 1996, all 25 regional capitals in Ukraine reported HIV,

primarily among drug injectors. In some cities, rates of HIV among IDUs rose from nearly

zero in 1994 to more than 50% two years later. Today, Ukraine is the most HIV-affected country in Europe

and Central Asia, with an estimated 260,000 infected between the ages of 15 - 49, or 1.13% of the population in this age range.

Prevalence among PWID – 21.5%. (Bio-behavioral Survey, 2011)

Page 11: Social science of HIV and hepatitis C in Russia and southeastern Europe

11

Social reasons: The social and economic disintegration that followed the collapse of the Soviet Union in 1991.

With the withdrawal of the Soviet Union in December 1991:

Police controls became ineffective, drugs more readily available, and corruption uncontrolled.

In the first 5 years following the demise of the Soviet Union, the magnitude of the illicit economy was estimated to have tripled, reaching more than 40% of the gross national product from 1994 through 1995.

Locally produced opiates and amphetamines proliferated. Registered drug users increased from 30,000 to 63,000 between 1990 and 1996.

State-supported services, including health care, were reduced or eliminated.

Robert Booth at all. 2013. AIDS Behav

Page 12: Social science of HIV and hepatitis C in Russia and southeastern Europe

12

Registered drug users in Central Asia (UNODC World Drug Report, 2010)

Page 13: Social science of HIV and hepatitis C in Russia and southeastern Europe

13

Russia547,000 – registered addicts

102.5 mln of age 15-64 Estimated Prevalence 1.64% Total ~1.68 mln drug users

Page 14: Social science of HIV and hepatitis C in Russia and southeastern Europe

14

HIV Incidence by Mode of Transmission in Russia, 1987-2008

Page 15: Social science of HIV and hepatitis C in Russia and southeastern Europe

15

HIV transmission in Ukraine

Injection of drugsFrom mother to childSexual

Undetermined

Data of the Ukrainian AIDS Center

1995 - 1998

79,1%

3,8%2,8% 14,3%

Page 16: Social science of HIV and hepatitis C in Russia and southeastern Europe

16

Mode of Transmission Attributed to HIV

Cases by Gender in Ukraine, 2005-2011

Page 17: Social science of HIV and hepatitis C in Russia and southeastern Europe

17

Monitoring of Epidemic Trends

The main indicator– HIV prevalence among high-risk groups

Example – HIV prevalence among IDUs using drugs at least 2 years

2005г. – 23,8%2006г. – 20,2%2007г. – 18,9%

Page 18: Social science of HIV and hepatitis C in Russia and southeastern Europe

18

HIV prevalence among recent IDUs and IDU coverage by prevention programs, 2004-2011

• HIV Prevalence among recent IDUs (injecting for less than 3 years) was used as proxy incidence.

• Median value for 8 cities: Donetsk, Lutsk, Odessa, Poltava, Simferopol, Summy, Kharkov, Kherson.

• Prevention program coverage at last 12 month

• With increasing coverage over the last 6 years, HIV incidence has been declining significantly: from 29.9% percent in 2004 to 5.5% in 2011

2004

2005

2006

2007

2008

2009

2010

2011

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

0

5000

10000

15000

20000

25000

30000

35000

40000

Распространенность ВИЧ, %HIV prevalence, % Coverage

Page 19: Social science of HIV and hepatitis C in Russia and southeastern Europe

19

Prevalence of Hepatitis C among People who Inject Drugs*

*Cumulative information on infections over the last decades. Incidence of hepatitis C infections is unavailable in most countries.

Page 20: Social science of HIV and hepatitis C in Russia and southeastern Europe

20

Page 21: Social science of HIV and hepatitis C in Russia and southeastern Europe

21

STOP HARM REDUCTION!NEEDLE / SYRINGES EXCHANGE

PROGRAMS STIMULATE A TOLERANCE TOWARD PATIENTS WITH DRUG ABUSE AND VIOLATORS OF RUSSIAN FEDERATION’ LEGISLATION. RUSSIAN MINISTER OF HEALTH (2010)

Page 22: Social science of HIV and hepatitis C in Russia and southeastern Europe

22

Page 23: Social science of HIV and hepatitis C in Russia and southeastern Europe

23

• “In honor of Hitler it was named Adolphine and later Dolophine”.• “In the majority of nations methadone was completely prohibited. Any supply of this compound is stored and safely put away completely in the West”. • “Methadone was used as a detonator in conducting so called ‘colored’ revolutions. It was established with the breakup of Yugoslavia: there was a factory made for the production of methadone and it was distributed for free, until civil unrest. Then the factory was closed and thousands of drug users began to vandalize and destroy everything in their way”.

“Rossiyskaya Gazeta”

About methadone

Page 24: Social science of HIV and hepatitis C in Russia and southeastern Europe

24

Russian Authorities are categorically against OST

“EC countries make a pressure to us for

implementation of OST. They want we do treat drug addicts by other drugs”.

FDCS will not allow to stick Russia methadone therapy.

“The USA and some European countries support us”.

Page 25: Social science of HIV and hepatitis C in Russia and southeastern Europe

25I se

mester

2008

II sem

ester

2008

I semest

er 200

9

II sem

ester

2009

I semest

er 201

0

II sem

ester

2010

I semest

er 201

1

II sem

ester

2011

I semest

er 201

2

II sem

ester

2012

I semest

er 201

30

1000

2000

3000

4000

5000

6000

7000

8000

52

816 864 831 831 842 814 804 835 831 821827 670

1640 1640

3221

4729

54735828

61596508 6773

Substituton Maintenance Therapy in Ukraine, 2008-2013

Buprenorphine Methadone

Page 26: Social science of HIV and hepatitis C in Russia and southeastern Europe

26

804 798 795 806 804 817 835 845 839 840 846 830

5828 5852 5883 5977 6054 6084 6159 6249 6263 6283 6344 6431

0

1000

2000

3000

4000

5000

6000

7000

January February March April May June July August September October November December

Number of OST patients in Ukraine, 2012

Buprenorphine Methadone

Page 27: Social science of HIV and hepatitis C in Russia and southeastern Europe

27

Study of Structural Barriers to HIV Prevention and Treatment Among Drug Injectors in Odessa, Ukraine (2010).

• Legal and economy collapse leaded to increasing risky behavior.

• The epidemic is largely sustained by the lack of government resources devoted to the problem, the continued risky drug using practices of injection and,

perhaps most importantly by the risk environment surrounding drug users.• Collaboration and

especially financial support of government to NGOs is very poor.

Page 28: Social science of HIV and hepatitis C in Russia and southeastern Europe

28

Opinions of Most Effective Strategies for Treating Addiction

(N=239)

IncarcerationReligion

MedicationFamily supportRehabilitation

EmploymentSubstitution Therapy

DetoxNew environment

Folk Medicine

0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.018.9

17.714.0

11.910.7

8.27.4

4.54.1

0.8

Percent (%) Responding. F.Altice et al. 2013

Page 29: Social science of HIV and hepatitis C in Russia and southeastern Europe

29

CONCLUSIONSMany social barriers in FSU countries

continue to support the epidemics (HIV & HCV).

Joint efforts needed to change drug policy, drug treatment with HIV.HCV prevention; and eliminate stigma from PWID.

Drug policy and treatment/prevention approaches have to be based on scientific evidence.

Public health issues must be the priority

Page 30: Social science of HIV and hepatitis C in Russia and southeastern Europe

30

Contacts:[email protected]

Thank you for your

attention.